{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "CitationSubset": ["IM"], "OtherAbstract": [], "KeywordList": [], "GeneralNote": [], "OtherID": [], "InvestigatorList": [], "PMID": "29393397", "DateCompleted": {"Year": "2018", "Month": "08", "Day": "31"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "01", "Day": "18"}], "Language": ["eng"], "ELocationID": ["10.3892/ijo.2018.4248"], "Journal": {"ISSN": "1791-2423", "JournalIssue": {"Volume": "52", "Issue": "3", "PubDate": {"Year": "2018", "Month": "Mar"}}, "Title": "International journal of oncology", "ISOAbbreviation": "Int J Oncol"}, "ArticleTitle": "Development of single nanometer-sized ultrafine oxygen bubbles to overcome the hypoxia-induced resistance to radiation therapy via the suppression of hypoxia-inducible factor\u20111\u03b1.", "Pagination": {"StartPage": "679", "EndPage": "686", "MedlinePgn": "679-686"}, "Abstract": {"AbstractText": ["Radiation therapy can result in severe side-effects, including the development of radiation resistance. The aim of this study was to validate the use of oxygen nanobubble water to overcome resistance to radiation in cancer cell lines via the suppression of the hypoxia-inducible factor\u00a01-\u03b1 (HIF\u20111\u03b1) subunit. Oxygen nanobubble water was created using a newly developed method to produce nanobubbles in the single-nanometer range with the \u03a3PM-5 device. The size and concentration of the oxygen nanobubbles in the water was examined using a cryo-transmission electron microscope. The nanobubble size was ranged from 2 to 3\u00a0nm, and the concentration of the nanobubbles was calculated at 2x1018\u00a0particles/ml. Cell viability and HIF-1\u03b1 levels were evaluated in EBC\u20111 lung cancer and MDA\u2011MB\u2011231 breast cancer cells treated with or without the nanobubble water and radiation under normoxic and hypoxic conditions in vitro. The cancer cells grown in oxygen nanobubble-containing media exhibited a clear suppression of hypoxia-induced HIF\u20111\u03b1 expression compared to the cells grown in media made with distilled water. Under hypoxic conditions, the EBC\u20111 and MDA\u2011MB231 cells displayed resistance to radiation compared to the cells cultured under normoxic cells. The use of oxygen nanobubble medium significantly suppressed the hypoxia-induced resistance to radiation compared to the use of normal medium at 2, 6, 10 and 14\u00a0Gy doses. Importantly, the use of nanobubble media did not affect the viability and radiation sensitivity of the cancer cell lines, or the non\u2011cancerous cell line, BEAS\u20112B, under normoxic conditions. This newly created single-nanometer range oxygen nanobubble water, without any additives, may thus prove to be a promising agent which may be used to overcome the hypoxia-induced resistance of cancer cells to radiation via the suppression of HIF-1\u03b1."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan."}], "Identifier": [], "LastName": "Iijima", "ForeName": "Misaki", "Initials": "M"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Pharmacology and Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan."}], "Identifier": [], "LastName": "Gombodorj", "ForeName": "Navchaa", "Initials": "N"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Sigma Technology Inc., Hitachinaka, Ibaraki 312-0053, Japan."}], "Identifier": [], "LastName": "Tachibana", "ForeName": "Yoshiaki", "Initials": "Y"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Sigma Technology Inc., Hitachinaka, Ibaraki 312-0053, Japan."}], "Identifier": [], "LastName": "Tachibana", "ForeName": "Kohsuke", "Initials": "K"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan."}], "Identifier": [], "LastName": "Yokobori", "ForeName": "Takehiko", "Initials": "T"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Sigma Technology Inc., Hitachinaka, Ibaraki 312-0053, Japan."}], "Identifier": [], "LastName": "Honma", "ForeName": "Kyoko", "Initials": "K"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Pharmacology and Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan."}], "Identifier": [], "LastName": "Nakano", "ForeName": "Takashi", "Initials": "T"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Big Data Center for Integrative Analysis, Gunma University Initiative for Advance Research (GIAR), Maebashi, Gunma 371-8511, Japan."}], "Identifier": [], "LastName": "Asao", "ForeName": "Takayuki", "Initials": "T"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Ultra-High Voltage Electron Microscopy, Osaka University, Ibaraki, Osaka 567-0047, Japan."}], "Identifier": [], "LastName": "Kuwahara", "ForeName": "Ryusuke", "Initials": "R"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Ultra-High Voltage Electron Microscopy, Osaka University, Ibaraki, Osaka 567-0047, Japan."}], "Identifier": [], "LastName": "Aoyama", "ForeName": "Kazuhiro", "Initials": "K"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Ultra-High Voltage Electron Microscopy, Osaka University, Ibaraki, Osaka 567-0047, Japan."}], "Identifier": [], "LastName": "Yasuda", "ForeName": "Hidehiro", "Initials": "H"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Vascular Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA."}], "Identifier": [], "LastName": "Kelly", "ForeName": "Matthew", "Initials": "M"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan."}], "Identifier": [], "LastName": "Kuwano", "ForeName": "Hiroyuki", "Initials": "H"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Vascular Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA."}], "Identifier": [], "LastName": "Yamanouchi", "ForeName": "Dai", "Initials": "D"}], "GrantList": [{"GrantID": "T32 HL110853", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Validation Study"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Int J Oncol", "NlmUniqueID": "9306042", "ISSNLinking": "1019-6439"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "HIF1A protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoxia-Inducible Factor 1, alpha Subunit"}, {"RegistryNumber": "059QF0KO0R", "NameOfSubstance": "Water"}, {"RegistryNumber": "S88TT14065", "NameOfSubstance": "Oxygen"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Cell Culture Techniques"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Hypoxia"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hypoxia-Inducible Factor 1, alpha Subunit"}, {"QualifierName": ["radiotherapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["administration & dosage", "chemistry"], "DescriptorName": "Oxygen"}, {"QualifierName": ["drug effects"], "DescriptorName": "Radiation Tolerance"}, {"QualifierName": ["chemistry"], "DescriptorName": "Water"}], "CoiStatement": "<b>Competing interests</b>. The authors M.I., N.G., T.Y., T.A., T.N., T.A., R.K., K.A., H.Y., H.K. and M.K., declare that they have no competing interests. Y.T., K.T., and K.H. are co-inventors of a patent (Tachibana Y, Tachibana K, Harada K, Sasajima S, Tamahashi K, Honma K, Matsumoto Y: METHOD, A BUBBLE GENERATING NOZZLE, AND AN APPARATUS FOR GENERATING MICRO-NANO BUBBLES JP.5555892, JP/PCT/2013/066902, Filed August 29, 2013; issued July 23, 2014), which has been filed in relation to the formulation of nanobubble described in the study. Y.T., K.T. and D.Y. are co-inventors of a patent (Yamannouchi D, Tachibana Y, Tachibana K: AQUEOUS SOLUTION CAPABLE OF BEING ADMINISTERED TO LIVING BODY, AND METHOD FOR PRODUCING SAME. WO 2017195852. JP/PCT2017/017779, Filed November 05, 2017) (Yamanouchi D, Tachibana Y, Tchibana K: AQUEOUS SOLUTION CONTAINING OZONE NANOBUBBLES, METHOD FOR PRODUCING SAME AND UTILIZATION OF AQUEOUS SOLUTION CONTAINING OZONE NANOBUBBLES. WO 2017199827. JP/PCT/2017/017781. Filed November 05, 2017.), which has been filed in relation to the formulation and application of nanobubble described in the study."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Nakagawa K, Watanabe SI, Kunitoh H, Asamura H, The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: Past activities, current status and future direction. Jpn J Clin Oncol. 2017;47:194\u2013199. doi: 10.1093/jjco/hyw169.", "ArticleIdList": ["10.1093/jjco/hyw169", "28365781"]}, {"Citation": "Arriagada R, Auperin A, Burdett S, Higgins JP, Johnson DH, Le Chevalier T, Le Pechoux C, Parmar MK, Pignon JP, Souhami RL, et al. NSCLC Meta-analyses Collaborative Group Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: Two meta-analyses of individual patient data. Lancet. 2010;375:1267\u20131277. doi: 10.1016/S0140-6736(10)60059-1.", "ArticleIdList": ["10.1016/S0140-6736(10)60059-1", "PMC2853682", "20338627"]}, {"Citation": "Fiteni F, Westeel V, Bonnetain F. Surrogate endpoints for overall survival in lung cancer trials: A review. Expert Rev Anticancer Ther. 2017;17:447\u2013454. doi: 10.1080/14737140.2017.1316196.", "ArticleIdList": ["10.1080/14737140.2017.1316196", "28399678"]}, {"Citation": "Shafiq J, Hanna TP, Vinod SK, Delaney GP, Barton MB. A Population-based Model of Local Control and Survival Benefit of Radiotherapy for Lung Cancer. Clin Oncol (R Coll Radiol) 2016;28:627\u2013638. doi: 10.1016/j.clon.2016.05.006.", "ArticleIdList": ["10.1016/j.clon.2016.05.006", "27260488"]}, {"Citation": "Yang CF, Chan DY, Speicher PJ, Gulack BC, Wang X, Hartwig MG, Onaitis MW, Tong BC, D\u2019Amico TA, Berry MF, et al. Role of adjuvant therapy in a population-based cohort of patients with early-stage small-cell lung cancer. J Clin Oncol. 2016;34:1057\u20131064. doi: 10.1200/JCO.2015.63.8171.", "ArticleIdList": ["10.1200/JCO.2015.63.8171", "PMC4933132", "26786925"]}, {"Citation": "Giridhar P, Mallick S, Rath GK, Julka PK. Radiation induced lung injury: Prediction, assessment and management. Asian Pac J Cancer Prev. 2015;16:2613\u20132617. doi: 10.7314/APJCP.2015.16.7.2613.", "ArticleIdList": ["10.7314/APJCP.2015.16.7.2613", "25854336"]}, {"Citation": "Bradley J, Movsas B. Radiation pneumonitis and esophagitis in thoracic irradiation. Cancer Treat Res. 2006;128:43\u201364. doi: 10.1007/0-387-25354-8_4.", "ArticleIdList": ["10.1007/0-387-25354-8_4", "16335013"]}, {"Citation": "Marks LB, Yu X, Vujaskovic Z, Small W, Jr, Folz R, Anscher MS. Radiation-induced lung injury. Semin Radiat Oncol. 2003;13:333\u2013345. doi: 10.1016/S1053-4296(03)00034-1.", "ArticleIdList": ["10.1016/S1053-4296(03)00034-1", "12903021"]}, {"Citation": "Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer. 2008;8:967\u2013975. doi: 10.1038/nrc2540.", "ArticleIdList": ["10.1038/nrc2540", "PMC3140692", "18987634"]}, {"Citation": "Kunz M, Ibrahim SM. Molecular responses to hypoxia in tumor cells. Mol Cancer. 2003;2:23. doi: 10.1186/1476-4598-2-23.", "ArticleIdList": ["10.1186/1476-4598-2-23", "PMC155638", "12740039"]}, {"Citation": "Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1) Mol Pharmacol. 2006;70:1469\u20131480. doi: 10.1124/mol.106.027029.", "ArticleIdList": ["10.1124/mol.106.027029", "16887934"]}, {"Citation": "Semenza GL. Hypoxia-inducible factors: Mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012;33:207\u2013214. doi: 10.1016/j.tips.2012.01.005.", "ArticleIdList": ["10.1016/j.tips.2012.01.005", "PMC3437546", "22398146"]}, {"Citation": "Keith B, Johnson RS, Simon MC. HIF1\u03b1 and HIF2\u03b1: Sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer. 2011;12:9\u201322. doi: 10.1038/nrc3183.", "ArticleIdList": ["10.1038/nrc3183", "PMC3401912", "22169972"]}, {"Citation": "Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011;11:393\u2013410. doi: 10.1038/nrc3064.", "ArticleIdList": ["10.1038/nrc3064", "21606941"]}, {"Citation": "Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist. 2002;7:492\u2013508. doi: 10.1634/theoncologist.7-6-492.", "ArticleIdList": ["10.1634/theoncologist.7-6-492", "12490737"]}, {"Citation": "Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004;4:437\u2013447. doi: 10.1038/nrc1367.", "ArticleIdList": ["10.1038/nrc1367", "15170446"]}, {"Citation": "Shannon AM, Bouchier-Hayes DJ, Condron CM, Toomey D. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev. 2003;29:297\u2013307. doi: 10.1016/S0305-7372(03)00003-3.", "ArticleIdList": ["10.1016/S0305-7372(03)00003-3", "12927570"]}, {"Citation": "Shimoda LA, Semenza GL. HIF and the lung: Role of hypoxia-inducible factors in pulmonary development and disease. Am J Respir Crit Care Med. 2011;183:152\u2013156. doi: 10.1164/rccm.201009-1393PP.", "ArticleIdList": ["10.1164/rccm.201009-1393PP", "PMC3159088", "21242594"]}, {"Citation": "Goudar RK, Vlahovic G. Hypoxia, angiogenesis, and lung cancer. Curr Oncol Rep. 2008;10:277\u2013282. doi: 10.1007/s11912-008-0043-6.", "ArticleIdList": ["10.1007/s11912-008-0043-6", "18778551"]}, {"Citation": "Chen X, Wang P, Guo F, Wang X, Wang J, Xu J, Yuan D, Zhang J, Shao C. Autophagy enhanced the radioresistance of non-small cell lung cancer by regulating ROS level under hypoxia condition. Int J Radiat Biol. 2017;93:764\u2013770. doi: 10.1080/09553002.2017.1325025.", "ArticleIdList": ["10.1080/09553002.2017.1325025", "28463025"]}, {"Citation": "Ren W, Mi D, Yang K, Cao N, Tian J, Li Z, Ma B. The expression of hypoxia-inducible factor-1\u03b1 and its clinical significance in lung cancer: A systematic review and meta-analysis. Swiss Med Wkly. 2013;143:w13855.", "ArticleIdList": ["24018850"]}, {"Citation": "Yang SL, Ren QG, Wen L, Hu JL. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: A systematic review with meta-analysis. J Huazhong Univ Sci Technolog Med Sci. 2016;36:321\u2013327. doi: 10.1007/s11596-016-1586-7.", "ArticleIdList": ["10.1007/s11596-016-1586-7", "27376798"]}, {"Citation": "Hung JJ, Yang MH, Hsu HS, Hsu WH, Liu JS, Wu KJ. Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax. 2009;64:1082\u20131089. doi: 10.1136/thx.2009.115691.", "ArticleIdList": ["10.1136/thx.2009.115691", "19778933"]}, {"Citation": "Shibamoto Y, Sugie C, Ito M, Ogino H. The Japanese experiences with hypoxia-targeting pharmacoradiotherapy: From hypoxic cell sensitisers to radiation-activated prodrugs. Expert Opin Pharmacother. 2004;5:2459\u20132467. doi: 10.1517/14656566.5.12.2459.", "ArticleIdList": ["10.1517/14656566.5.12.2459", "15571464"]}, {"Citation": "Owen J, McEwan C, Nesbitt H, Bovornchutichai P, Averre R, Borden M, McHale AP, Callan JF, Stride E. Reducing tumour hypoxia via oral administration of oxygen nanobubbles. PLoS One. 2016;11:e0168088. doi: 10.1371/journal.pone.0168088.", "ArticleIdList": ["10.1371/journal.pone.0168088", "PMC5201233", "28036332"]}, {"Citation": "Agarwal A, Ng WJ, Liu Y. Principle and applications of microbubble and nanobubble technology for water treatment. Chemosphere. 2011;84:1175\u20131180. doi: 10.1016/j.chemosphere.2011.05.054.", "ArticleIdList": ["10.1016/j.chemosphere.2011.05.054", "21689840"]}, {"Citation": "Tachibana Y, Tachibana K, Harada K, Sasajima S, Tamahashi K, Honma K, Matsumoto Y. Method, a bubble generating nozzle, and an apparatus for generating micro-nano bubbles. Sigma Technology, Inc, JP, PCT/JP2013/066902. 2013 Aug 29; Filed. issued July 23, 2014."}, {"Citation": "Takahashi M, Chiba K, Li P. Free-radical generation from collapsing microbubbles in the absence of a dynamic stimulus. J Phys Chem B. 2007;111:1343\u20131347. doi: 10.1021/jp0669254.", "ArticleIdList": ["10.1021/jp0669254", "17253740"]}, {"Citation": "Kheir JN, Polizzotti BD, Thomson LM, O\u2019Connell DW, Black KJ, Lee RW, Wilking JN, Graham AC, Bell DC, McGowan FX. Bulk manufacture of concentrated oxygen gas-filled microparticles for intravenous oxygen delivery. Adv Healthc Mater. 2013;2:1131\u20131141. doi: 10.1002/adhm.201200350.", "ArticleIdList": ["10.1002/adhm.201200350", "23471884"]}, {"Citation": "Vaupel P, Thews O, Hoeckel M. Treatment resistance of solid tumors: Role of hypoxia and anemia. Med Oncol. 2001;18:243\u2013259. doi: 10.1385/MO:18:4:243.", "ArticleIdList": ["10.1385/MO:18:4:243", "11918451"]}, {"Citation": "Kim BM, Hong Y, Lee S, Liu P, Lim JH, Lee YH, Lee TH, Chang KT, Hong Y. Therapeutic implications for overcoming radiation resistance in cancer therapy. Int J Mol Sci. 2015;16:26880\u201326913. doi: 10.3390/ijms161125991.", "ArticleIdList": ["10.3390/ijms161125991", "PMC4661850", "26569225"]}, {"Citation": "Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721\u2013732. doi: 10.1038/nrc1187.", "ArticleIdList": ["10.1038/nrc1187", "13130303"]}, {"Citation": "Chan DA, Krieg AJ, Turcotte S, Giaccia AJ. HIF gene expression in cancer therapy. Methods Enzymol. 2007;435:323\u2013345. doi: 10.1016/S0076-6879(07)35016-7.", "ArticleIdList": ["10.1016/S0076-6879(07)35016-7", "17998061"]}, {"Citation": "Xia Y, Choi HK, Lee K. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. Eur J Med Chem. 2012;49:24\u201340. doi: 10.1016/j.ejmech.2012.01.033.", "ArticleIdList": ["10.1016/j.ejmech.2012.01.033", "22305612"]}, {"Citation": "Semenza GL. Hypoxia-inducible factor 1 and cancer pathogenesis. IUBMB Life. 2008;60:591\u2013597. doi: 10.1002/iub.93.", "ArticleIdList": ["10.1002/iub.93", "18506846"]}, {"Citation": "Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M. Targeting free radicals in oxidative stress-related human diseases. Trends Pharmacol Sci. 2017;38:592\u2013607. doi: 10.1016/j.tips.2017.04.005.", "ArticleIdList": ["10.1016/j.tips.2017.04.005", "28551354"]}, {"Citation": "G\u00e0o X, Sch\u00f6ttker B. Reduction-oxidation pathways involved in cancer development: A systematic review of literature reviews. Oncotarget. 2017;8:51888\u201351906.", "ArticleIdList": ["PMC5584299", "28881698"]}, {"Citation": "Daly BD, Cerfolio RJ, Krasna MJ. Role of surgery following induction therapy for stage III non-small cell lung cancer. Surg Oncol Clin N Am. 2011;20:721\u2013732. doi: 10.1016/j.soc.2011.07.006.", "ArticleIdList": ["10.1016/j.soc.2011.07.006", "21986268"]}, {"Citation": "Xu YP, Li B, Xu XL, Mao WM. Is there a survival benefit in patients with stage IIIA (N2) non-small cell lung cancer receiving neoadjuvant chemotherapy and/or radiotherapy prior to surgical resection: A systematic review and meta-analysis. Medicine (Baltimore) 2015;94:e879. doi: 10.1097/MD.0000000000000879.", "ArticleIdList": ["10.1097/MD.0000000000000879", "PMC4616485", "26061306"]}, {"Citation": "Baker S, Dahele M, Lagerwaard FJ, Senan S. A critical review of recent developments in radiotherapy for non-small cell lung cancer. Radiat Oncol. 2016;11:115. doi: 10.1186/s13014-016-0693-8.", "ArticleIdList": ["10.1186/s13014-016-0693-8", "PMC5012092", "27600665"]}, {"Citation": "Campbell BA, Ball D, Mornex F. Multidisciplinary lung cancer meetings: Improving the practice of radiation oncology and facing future challenges. Respirology. 2015;20:192\u2013198. doi: 10.1111/resp.12459.", "ArticleIdList": ["10.1111/resp.12459", "25581058"]}, {"Citation": "Scagliotti GV, Novello S, Rapetti S, Papotti M. Current state-of-the-art therapy for advanced squamous cell lung cancer. Am Soc Clin Oncol Educ Book. 2013;33:354\u2013358. doi: 10.1200/EdBook_AM.2013.33.354.", "ArticleIdList": ["10.1200/EdBook_AM.2013.33.354", "23714545"]}, {"Citation": "Haasbeek CJ, Slotman BJ, Senan S. Radiotherapy for lung cancer: Clinical impact of recent technical advances. Lung Cancer. 2009;64:1\u20138. doi: 10.1016/j.lungcan.2008.07.008.", "ArticleIdList": ["10.1016/j.lungcan.2008.07.008", "18771814"]}, {"Citation": "Cascales A, Martinetti F, Belemsagha D, Le Pechoux C. Challenges in the treatment of early non-small cell lung cancer: What is the standard, what are the challenges and what is the future for radiotherapy? Transl Lung Cancer Res. 2014;3:195\u2013204.", "ArticleIdList": ["PMC4367700", "25806301"]}, {"Citation": "Huo M, Gorayski P, Pinkham MB, Lehman M. Advances in radiotherapy technology for non-small cell lung cancer: What every general practitioner should know. Aust Fam Physician. 2016;45:805\u2013809.", "ArticleIdList": ["27806449"]}, {"Citation": "Bhandari P, Wang X, Irudayaraj J. Oxygen nanobubble tracking by light scattering in single cells and tissues. ACS Nano. 2017;11:2682\u20132688. doi: 10.1021/acsnano.6b07478.", "ArticleIdList": ["10.1021/acsnano.6b07478", "28267921"]}, {"Citation": "Bhandari PN, Cui Y, Elzey BD, Goergen CJ, Long CM, Irudayaraj J. Oxygen nanobubbles revert hypoxia by methylation programming. Sci Rep. 2017;7:9268. doi: 10.1038/s41598-017-08988-7.", "ArticleIdList": ["10.1038/s41598-017-08988-7", "PMC5570893", "28839175"]}, {"Citation": "Luo H, Wang L, Schulte BA, Yang A, Tang S, Wang GY. Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells. Int J Oncol. 2013;43:1999\u20132006. doi: 10.3892/ijo.2013.2141.", "ArticleIdList": ["10.3892/ijo.2013.2141", "PMC3834547", "24141489"]}, {"Citation": "Millet P, Granotier C, Etienne O, Boussin FD. Radiation-induced upregulation of telomerase activity escapes PI3-kinase inhibition in two malignant glioma cell lines. Int J Oncol. 2013;43:375\u2013382. doi: 10.3892/ijo.2013.1970.", "ArticleIdList": ["10.3892/ijo.2013.1970", "PMC3775596", "23727752"]}, {"Citation": "Lechtman E, Pignol JP. Interplay between the gold nanoparticle sub-cellular localization, size, and the photon energy for radiosensitization. Sci Rep. 2017;7:13268. doi: 10.1038/s41598-017-13736-y.", "ArticleIdList": ["10.1038/s41598-017-13736-y", "PMC5643548", "29038517"]}]}], "History": [{"Year": "2017", "Month": "6", "Day": "28"}, {"Year": "2018", "Month": "1", "Day": "12"}, {"Year": "2018", "Month": "2", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "18"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29393397", "PMC5807044", "10.3892/ijo.2018.4248"]}}]}